mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
BRD9647 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |